Long Covid
Research Update: Recent long covid findings and our clinical trial
The past months have been very busy on the Long Covid research front, both for our research planning as well as Long Covid research in
Top 20 papers on Long Covid – Prevalence, range of disease, Long Covid in children, and more
We get a lot of questions as to what is the best scientific evidence that demonstrates various aspects of Long Covid. To facilitate our sharing
TLC Sessions Podcast interviews the Research-Aid Networks team
On April 14, the Research-Aid Networks team published a hypothesis paper in Frontiers in Immunology that could potentially explain many of Long Covid’s widely varying symptoms. In early
Long Covid Expert Interview with Gez Medinger: Episode 33 – The Acid-Base Disruption Hypothesis for Long Covid
In early May, the Research-Aid Networks research team was interviewed by Gez Medinger, co-author of the Long Covid handbook and known from his Long Covid
New hypothesis on Long Covid published by Research-Aid Networks
The Research-Aid Networks team has published a hypothesis that could potentially explain many of Long Covid’s widely varying symptoms. The research article describing this hypothesis
This is The Long Haul, a look at some of the Long Covid stories we have heard
In the last two years, The Long Haul, an online series on Long Covid, has looked into what Long Covid is and what it means for
The Long Haul interviews Long Covid SOS co-founder
The long term consequences of COVID-19 known as Long Covid or post-acute sequelae of COVID-19 (PASC) has, since 2020, affected millions of lives around the
Rapid Response to nationwide cohort study: Long covid outcomes at one year after mild SARS-CoV-2 infection
On January 18, 2023, Research-Aid Networks and others sent a rapid response to BMJ regarding the study ‘Long covid outcomes at one year after mild
Concerns about study that minimizes the risks of Long COVID in children.
We recently published a collaborative commentary in Lancet Child & Adolescent Health raising methodological concerns about a recent study that minimizes the risks of Long COVID in children.
Promotion of non-evidence based therapeutics in Long COVID support groups
We recently published a collaborative article in Nature Medicine discussing the promotion of non-evidence based therapeutics in Long COVID support groups.